BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6099306)

  • 21. Evaluation of the genetic stability of Sabin strains and the consistency of inactivated poliomyelitis vaccine made from Sabin strains using direct deep-sequencing.
    Deng Y; Cai W; Li J; Li Y; Yang X; Ma Y; Yao Y; Yang L; Shi L; Sun M
    Vaccine; 2019 Jan; 37(1):130-136. PubMed ID: 30467062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interference with vaccinia virus growth caused by insertion of the coding sequence for poliovirus protease 2A.
    Turner PC; Young DC; Flanegan JB; Moyer RW
    Virology; 1989 Dec; 173(2):509-21. PubMed ID: 2556841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 polioviruses.
    Stanway G; Cann AJ; Hauptmann R; Mountford RC; Clarke LD; Reeve P; Minor PD; Schild GC; Almond JW
    Eur J Biochem; 1983 Oct; 135(3):529-33. PubMed ID: 6311539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infectious cDNA clone of the RA27/3 vaccine strain of Rubella virus.
    Pugachev KV; Galinski MS; Frey TK
    Virology; 2000 Jul; 273(1):189-97. PubMed ID: 10891421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.
    Martín J; Minor PD
    J Virol; 2002 Jun; 76(11):5339-49. PubMed ID: 11991962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic analysis of the attenuation phenotype of poliovirus type 1.
    Omata T; Kohara M; Kuge S; Komatsu T; Abe S; Semler BL; Kameda A; Itoh H; Arita M; Wimmer E
    J Virol; 1986 May; 58(2):348-58. PubMed ID: 3009852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine.
    Mento SJ; Weeks-Levy C; Tatem JM; Gorgacz EJ; Waterfield WF
    Dev Biol Stand; 1993; 78():93-9; discussion 99-100. PubMed ID: 8388835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.
    Macadam AJ; Pollard SR; Ferguson G; Skuce R; Wood D; Almond JW; Minor PD
    Virology; 1993 Jan; 192(1):18-26. PubMed ID: 8390752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restriction map of double-stranded DNA copy synthesized from poliovirus Sabin 1 RNA.
    Nomoto A; Toyoda H; Imura N; Noguchi S; Sekiya T
    J Biochem; 1982 May; 91(5):1593-600. PubMed ID: 6284728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategy for construction of live picornavirus vaccines.
    Nomoto A; Iizuka N; Kohara M; Arita M
    Vaccine; 1988 Apr; 6(2):134-7. PubMed ID: 2838985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping and sequencing of RNAs without recourse to molecular cloning: application to RNAs of the Sabin 1 strain of poliovirus and its defective interfering particles.
    Omata T; Horie H; Kuge S; Imura N; Nomoto A
    J Biochem; 1986 Jan; 99(1):207-17. PubMed ID: 3007445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of heterologous nucleic acids after uptake by mammalian cells.
    Graeber I; Tischer J; Heinrich J; Hachula G; López-Pila JM
    DNA Cell Biol; 1998 Nov; 17(11):945-9. PubMed ID: 9839803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An authentic 3' noncoding region is necessary for efficient poliovirus replication.
    Brown DM; Cornell CT; Tran GP; Nguyen JH; Semler BL
    J Virol; 2005 Sep; 79(18):11962-73. PubMed ID: 16140772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis.
    Foiadelli T; Savasta S; Battistone A; Kota M; Passera C; Fiore S; Bino S; Amato C; Lozza A; Marseglia GL; Fiore L
    BMC Infect Dis; 2016 Jun; 16():277. PubMed ID: 27287521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strong inclination toward transition mutation in nucleotide substitutions by poliovirus replicase.
    Kuge S; Kawamura N; Nomoto A
    J Mol Biol; 1989 May; 207(1):175-82. PubMed ID: 2544735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of 3'-end sequences in infectivity of poliovirus transcripts made in vitro.
    Sarnow P
    J Virol; 1989 Jan; 63(1):467-70. PubMed ID: 2535751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the attenuation phenotype of polio vaccines: poliovirus RNA polymerase derived from Sabin type 1 sequence is temperature sensitive in the uridylylation of VPg.
    Paul AV; Mugavero J; Yin J; Hobson S; Schultz S; van Boom JH; Wimmer E
    Virology; 2000 Jun; 272(1):72-84. PubMed ID: 10873750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restriction map of poliovirus type 2 cDNA.
    Kopecka H; van der Werf S; Bregegere F; Kitamura N; Dreano M; Rothberg PG; Wimmer E; Kourilsky P; Girard M
    Dev Biol Stand; 1981; 50():301-9. PubMed ID: 6176488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the poliovirus genome from infectious cDNA is dependent upon arrangements of eukaryotic and prokaryotic sequences in recombinant plasmids.
    Kuhn RJ; Wimmer E; Semler BL
    Virology; 1987 Apr; 157(2):560-4. PubMed ID: 3029989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential use of poliovirus as a vector.
    Girard M; Martin A; van der Werf S
    Biologicals; 1993 Dec; 21(4):371-7. PubMed ID: 8024753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.